Pain relief for patients undergoing a total hip replacement for osteoarthritis. Musculoskeletal Diseases
Conditions
Interventions
Patients undergoing total hip arthroplasty under spinal anaesthetic were recruited for the study and prospectively randomised into groups
A & B. Treatment allocations were randomised using sealed opaque envelopes. Group A will receive the periarticular injection which will be administered to the agreed protocol by the surgeon during the
50ml anterior to the acetabular cup, 50ml to the psoas compartment and 50ml to the subcutaneous tissues. Group B will not receive the periarticular injection. Patients will be consented on the morning
Sponsors
Health Service Executive
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Patient over 18 years old with osteoarthritis who have been scheduled for total hip arthroplasty
Exclusion criteria
Exclusion criteria: 1. Patients <18 years old 2. Patients with cognitive impairment 3. Previous diagnosis of a pain syndrome 4. Patient’s undergoing bilateral total hip arthroplasty or revision total hip arthroplasty
Countries
Ireland
Contacts
Public ContactRoss Condell
Outcome results
None listed